d fructose 1,6 bisphosphate (sodium salt hydrate)

D-Fructose-1,6-bisphosphate sodium salt hydrate is the intermediate in carbohydrate metabolism, including glycolysis and gluconeogenesis. During glycolysis, it is produced by phosphorylation of fructose-6-phosphate by phosphofructokinase. The reverse reaction mediated by fructose-1, 6-diphosphatase-1 is one of the rate-limiting steps of gluconeogenesis. The same reaction occurs in the chloroplasts of plants, D-Fructose-1,6-bisphosphate sodium salt hydrate as part of the reducing pentose phosphate cycle. Since cancer cells use glycolysis as a primary source of metabolic energy production, this pathway has become a major target for cancer chemotherapy.

Esafosfan trisodium (FDP trisodium) is a cytoprotective natural sugar phosphate for the potential treatment of sickle cell anemia, cardiovascular ischemia and asthma. It acts by stimulating anaerobic glycolysis which generates adenosine triphosphate under ischemic conditions.

D-Fructose-[13C6] 1,6-Bisphosphate (Sodium Salt) (Standard) is a reference standard of D-Fructose-[13C6] 1,6-Bisphosphate (Sodium Salt) intended for quantitative analysis, quality control, and related biochemical research applications.

Fosfructose trisodium octahydrate is an intermediate in carbohydrate metabolism, participating in glycolysis and gluconeogenesis. It acts as an inhibitor of bacterial acetate kinase and an allosteric activator of PKM2, exhibiting neuroprotective effects.

D-fructose-1,6-diphosphate (D-fructose-1,6-diphosphate), also known as Fosfructose, is a cytoprotective natural sugar phosphate. It functions by promoting anaerobic glycolysis, which generates adenosine triphosphate (ATP) under ischemic conditions. This compound holds potential for research in cardiovascular ischemia, sickle cell anemia, and asthma.